Malin Life Sciences Holdings Ltd 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-07 11:37 am Sale |
2022-08-31 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Ltd | 2,109,425 4.560% |
-280,554 (-11.74%) |
Filing |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Ltd | 2,389,979 5.450% |
30,554 (+1.29%) |
Filing |
| 2021-10-15 1:17 pm Purchase |
2021-10-15 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Ltd | 2,359,425 5.390% |
2,359,425 (New Position) |
Filing |